Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer (Industry)
Overall Status
Completed
CT.gov ID
NCT00161668
Collaborator
(none)
500
59
8.5

Study Details

Study Description

Brief Summary

This study is designed to assess the safety of Mylotarg therapy in routine practice.

Condition or Disease Intervention/Treatment Phase

Study Design

Study Type:
Observational
Observational Model:
Defined Population
Time Perspective:
Prospective
Official Title:
Prospective Observational Study of Mylotarg (Gemtuzumab Ozogamicin) in Usual Care
Study Start Date :
Oct 1, 2001

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Treated by Mylotarg

    • Provide ICF

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Tucson Arizona United States 85404
    2 Berkely California United States 94704
    3 Burbank California United States 91505
    4 Concord California United States 94520
    5 Loma Linda California United States 92354
    6 Los Angeles California United States 90095-1678
    7 San Francisco California United States 94143
    8 Sylmar California United States 91342
    9 Denver Colorado United States 80218
    10 Boynton Beach Florida United States 33435
    11 Plantation Florida United States 33324
    12 Stuart Florida United States 34994
    13 Tamarac Florida United States 33321
    14 Chicago Illinois United States 60611
    15 Chicago Illinois United States 60612-3838
    16 Chicago Illinois United States 60612-7323
    17 Chicago Illinois United States 60637
    18 Indianapolis Indiana United States 46202
    19 Iowa City Iowa United States 52242
    20 Lexington Kentucky United States 40536-0093
    21 Louisville Kentucky United States 40202
    22 Shrevport Louisiana United States 71130-3932
    23 Ann Arbor Michigan United States 48109-0999
    24 Grand Rapids Michigan United States 49503
    25 Kalamazoo Michigan United States 49007-3731
    26 Kalamazoo Michigan United States 49048
    27 Columbia Missouri United States 65203
    28 St. Louis Missouri United States 63141
    29 Neptune New Jersey United States 07754
    30 Albuquerque New Mexico United States 87109
    31 Bronx New York United States 10466
    32 Buffalo New York United States 14263
    33 New Hyde Park New York United States 11040
    34 New York New York United States 10019
    35 New York New York United States 10032
    36 Valhalla New York United States 10595
    37 Durham North Carolina United States 27705
    38 Winston-Salem North Carolina United States 27106
    39 Bismarck North Dakota United States 58501
    40 Akron Ohio United States 44302
    41 Canton Ohio United States 44718
    42 Cincinnati Ohio United States 45236
    43 Cleveland Ohio United States 44195
    44 Oklahoma City Oklahoma United States 72112
    45 Portland Oregon United States 97201
    46 Hershey Pennsylvania United States 17033-0850
    47 Philadelphia Pennsylvania United States 19104
    48 Philadelphia Pennsylvania United States 19107
    49 Pittsburgh Pennsylvania United States 15224
    50 Memphis Tennessee United States 38120
    51 Nashville Tennessee United States 37205
    52 Nashville Tennessee United States 37232-5505
    53 Houston Texas United States 77030
    54 Temple Texas United States 76508
    55 Arlington Virginia United States 22205
    56 Richmond Virginia United States 23298-0157
    57 Charleston West Virginia United States 25304
    58 Morgantown West Virginia United States 26506-9162
    59 Appleton Wisconsin United States 54911

    Sponsors and Collaborators

    • Wyeth is now a wholly owned subsidiary of Pfizer

    Investigators

    • Study Director: Medical Monitor, Wyeth is now a wholly owned subsidiary of Pfizer

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00161668
    Other Study ID Numbers:
    • 0903X-100847
    First Posted:
    Sep 12, 2005
    Last Update Posted:
    Mar 15, 2007
    Last Verified:
    Mar 1, 2007
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 15, 2007